MedTrace Logo

Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss

NCT04621773 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-11-09

No results posted yet for this study

Summary

STUDY AIM: to study the pregnancy outcomes and offspring development of patient with Unexplained Recurrent Pregnancy Loss Treated by PGS and spontaneous pregnancy, and to compare the health economic indicators and patient satisfaction of the two modes of pregnancy, so as to better guide the clinical treatment.

Conditions

  • Recurrent Pregnancy Loss
  • Preimplantation Genetic Screening

Interventions

PROCEDURE

Preimplantation Genetic Screening(exposure)

Preimplantation genetic screening (PGS) was developed in the late 1980s as an alternative to prenatal diagnosis for couples at risk of transmitting a genetic or chromosomal abnormality to their children. In embryos created through in vitro fertilisation (IVF), cells are biopsied and analysed using genetic tests such as polymerase chain reaction and fluorescent in situ hybridisation (FISH).

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Rong Li, M.D. · Center of Reproductive Medicine, Peking University Third Hospital

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2023-09-01
Completion
2025-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04621773 on ClinicalTrials.gov